{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:05:21Z","timestamp":1787025921169,"version":"build-2736575974"},"reference-count":54,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2023.0154","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T05:33:55Z","timestamp":1692855235000},"source":"Crossref","is-referenced-by-count":12,"title":["Methods of conservative intra-articular treatment for osteoarthritis of the hip and knee"],"prefix":"10.3238","author":[{"given":"Robert","family":"Ossendorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Thimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter C.","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Schildberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"10.3238\/arztebl.m2023.0154_ref1","doi-asserted-by":"crossref","unstructured":"Deutsche Gesellschaft f\u00fcr Orthop\u00e4die und Unfallchirurgie e.V. (DGOU): S2k-Leitlinie Gonarthrose. https:\/\/register.awmf.org\/assets\/guidelines\/033-004l_S2k_Gonarthrose_2018-01_1-verlaengert_01.pdf (last accessed on 6 July 2023).","DOI":"10.1007\/s41785-018-0381-z"},{"key":"10.3238\/arztebl.m2023.0154_ref2","unstructured":"Deutsche Gesellschaft f\u00fcr Orthop\u00e4die und Orthop\u00e4dische Chirurgie e.V. (DGOOC): S2k-Leitlinie Koxarthrose. https:\/\/register.awmf.org\/assets\/guidelines\/033-001l_S2k_Koxarthrose_2019-07_1_01.pdf (last accessed on 6 July 2023)."},{"key":"10.3238\/arztebl.m2023.0154_ref3","doi-asserted-by":"crossref","unstructured":"Hynes JP, Kavanagh EC: Complications in image-guided musculoskeletal injections. Skeletal Radiol 2022; 51: 2097–104.","DOI":"10.1007\/s00256-022-04076-8"},{"key":"10.3238\/arztebl.m2023.0154_ref4","doi-asserted-by":"crossref","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, et al.: OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019; 27: 1578–89.","DOI":"10.1016\/j.joca.2019.06.011"},{"key":"10.3238\/arztebl.m2023.0154_ref5","doi-asserted-by":"crossref","unstructured":"Bruy\u00e8re O, Honvo G, Veronese N, et al.: An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum 2019; 49: 337–50.","DOI":"10.1016\/j.semarthrit.2019.04.008"},{"key":"10.3238\/arztebl.m2023.0154_ref6","doi-asserted-by":"crossref","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, et al.: 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol 2020; 72: 220–33.","DOI":"10.1002\/art.41142"},{"key":"10.3238\/arztebl.m2023.0154_ref7","doi-asserted-by":"crossref","unstructured":"Neumann TR, Schrock SD, Sorell R, Vogeler T: Which intra-articular corticosteroid is most effective? EBPR 2020; 23: 31–2.","DOI":"10.1097\/EBP.0000000000000596"},{"key":"10.3238\/arztebl.m2023.0154_ref8","doi-asserted-by":"crossref","unstructured":"Najm A, Alunno A, Gwinnutt JM, Weill C, Berenbaum F: Efficacy of intra-articular corticosteroid injections in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Joint Bone Spine 2021; 88: 105198.","DOI":"10.1016\/j.jbspin.2021.105198"},{"key":"10.3238\/arztebl.m2023.0154_ref9","doi-asserted-by":"crossref","unstructured":"Ayub S, Kaur J, Hui M, et al.: Efficacy and safety of multiple intra-articular corticosteroid injections for osteoarthritis–a systematic review and meta-analysis of randomized controlled trials and observational studies. Rheumatology (Oxford) 2021; 60: 1629–39.","DOI":"10.1093\/rheumatology\/keaa808"},{"key":"10.3238\/arztebl.m2023.0154_ref10","doi-asserted-by":"crossref","unstructured":"McAlindon TE, LaValley MP, Harvey WF, et al.: Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA 2017; 317: 1967–75.","DOI":"10.1001\/jama.2017.5283"},{"key":"10.3238\/arztebl.m2023.0154_ref11","doi-asserted-by":"crossref","unstructured":"Zeng C, Lane NE, Hunter DJ, et al.: Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2019; 27: 855–62.","DOI":"10.1016\/j.joca.2019.01.007"},{"key":"10.3238\/arztebl.m2023.0154_ref12","doi-asserted-by":"crossref","unstructured":"McGarry JG, Daruwalla ZJ: The efficacy, accuracy and complications of corticosteroid injections of the knee joint. Knee Surg Sports Traumatol Arthrosc 2011; 19: 1649–54.","DOI":"10.1007\/s00167-010-1380-1"},{"key":"10.3238\/arztebl.m2023.0154_ref13","doi-asserted-by":"crossref","unstructured":"Baums MH, Aquilina J, P\u00e9rez-Prieto D, Sleiman O, Geropoulos G, Totlis T: Risk analysis of periprosthetic knee joint infection (PJI) in total knee arthroplasty after preoperative corticosteroid injection: a systematic review A study performed by the Early-Osteoarthritis group of ESSKA-European Knee Associates section. Arch Orthop Trauma Surg 2023;143: 2683–91.","DOI":"10.1007\/s00402-022-04532-z"},{"key":"10.3238\/arztebl.m2023.0154_ref14","doi-asserted-by":"crossref","unstructured":"Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE: Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthritis Cartilage 2011; 19: 611–9.","DOI":"10.1016\/j.joca.2010.09.014"},{"key":"10.3238\/arztebl.m2023.0154_ref15","doi-asserted-by":"crossref","unstructured":"Miller LE, Block JE: US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials. Clin Med Insights Arthritis Musculoskelet Disord 2013; 6: 57–63.","DOI":"10.4137\/CMAMD.S12743"},{"key":"10.3238\/arztebl.m2023.0154_ref16","doi-asserted-by":"crossref","unstructured":"Di Zhao, Pan JK, Yang WY, et al.: Intra-articular injections of platelet-rich plasma, adipose mesenchymal stem cells, and bone marrow mesenchymal stem cells associated with better outcomes than hyaluronic acid and saline in knee osteoarthritis: a systematic review and network meta-analysis. Arthroscopy 2021; 37: 2298–2314.e10.","DOI":"10.1016\/j.arthro.2021.02.045"},{"key":"10.3238\/arztebl.m2023.0154_ref17","doi-asserted-by":"crossref","unstructured":"Migliorini F, Driessen A, Quack V, et al.: Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: a Bayesian network meta-analysis. Arch Orthop Trauma Surg 2021; 141: 1473–90.","DOI":"10.1007\/s00402-020-03551-y"},{"key":"10.3238\/arztebl.m2023.0154_ref18","doi-asserted-by":"crossref","unstructured":"Gazendam A, Ekhtiari S, Bozzo A, Phillips M, Bhandari M: Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials. Br J Sports Med 2021; 55: 256–61.","DOI":"10.1136\/bjsports-2020-102179"},{"key":"10.3238\/arztebl.m2023.0154_ref19","doi-asserted-by":"crossref","unstructured":"Hummer CD, Angst F, Ngai W, et al.: High molecular weight Intraarticular hyaluronic acid for the treatment of knee osteoarthritis: a network meta-analysis. BMC Musculoskelet Disord 2020; 21: 702.","DOI":"10.1186\/s12891-020-03729-w"},{"key":"10.3238\/arztebl.m2023.0154_ref20","doi-asserted-by":"crossref","unstructured":"Chevalier X, Goupille P, Beaulieu AD, et al.: Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009; 61: 344–52.","DOI":"10.1002\/art.24096"},{"key":"10.3238\/arztebl.m2023.0154_ref21","doi-asserted-by":"crossref","unstructured":"Ohtori S, Orita S, Yamauchi K, et al.: Efficacy of direct injection of etanercept into knee joints for pain in moderate and severe knee osteoarthritis. Yonsei Med J 2015; 56: 1379–83.","DOI":"10.3349\/ymj.2015.56.5.1379"},{"key":"10.3238\/arztebl.m2023.0154_ref22","doi-asserted-by":"crossref","unstructured":"Wang J: Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: an open-label randomized controlled trial. J Int Med Res 2018; 46: 326–34.","DOI":"10.1177\/0300060517723182"},{"key":"10.3238\/arztebl.m2023.0154_ref23","doi-asserted-by":"crossref","unstructured":"Eckstein F, Hochberg MC, Guehring H, et al.: Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study. Ann Rheum Dis 2021; 80: 1062–9.","DOI":"10.1136\/annrheumdis-2020-219181"},{"key":"10.3238\/arztebl.m2023.0154_ref24","doi-asserted-by":"crossref","unstructured":"Lohmander LS, Hellot S, Dreher D, et al.: Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 2014; 66: 1820–31.","DOI":"10.1002\/art.38614"},{"key":"10.3238\/arztebl.m2023.0154_ref25","doi-asserted-by":"crossref","unstructured":"Schwappach J, Dryden SM, Salottolo KM: Preliminary trial of intra-articular LMWF-5A for osteoarthritis of the knee. Orthopedics 2017; 40: e49–e53.","DOI":"10.3928\/01477447-20160926-02"},{"key":"10.3238\/arztebl.m2023.0154_ref26","doi-asserted-by":"crossref","unstructured":"Yazici Y, McAlindon TE, Gibofsky A, et al.: A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2\/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Osteoarthritis Cartilage 2021; 29: 654–66.","DOI":"10.1016\/j.joca.2021.02.004"},{"key":"10.3238\/arztebl.m2023.0154_ref27","doi-asserted-by":"crossref","unstructured":"Deshmukh V, Hu H, Barroga C, et al.: A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 2018; 26: 18–27.","DOI":"10.1016\/j.joca.2017.08.015"},{"key":"10.3238\/arztebl.m2023.0154_ref28","doi-asserted-by":"crossref","unstructured":"Stevens RM, Ervin J, Nezzer J, et al.: Randomized, double-blind, placebo-controlled trial of intraarticular trans-capsaicin for pain associated with osteoarthritis of the knee. Arthritis Rheumatol 2019; 71: 1524–33.","DOI":"10.1002\/art.40894"},{"key":"10.3238\/arztebl.m2023.0154_ref29","doi-asserted-by":"crossref","unstructured":"Huang R, Li W, Zhao Y, Yang F, Xu M: Clinical efficacy and safety of stem cell therapy for knee osteoarthritis: a meta-analysis. Medicine (Baltimore) 2020; 99: e19434.","DOI":"10.1097\/MD.0000000000019434"},{"key":"10.3238\/arztebl.m2023.0154_ref30","doi-asserted-by":"crossref","unstructured":"Belk JW, Houck DA, Littlefield CP, et al.: Platelet-rich plasma versus hyaluronic acid for hip osteoarthritis yields similarly beneficial short-term clinical outcomes: a systematic review and meta-analysis of level I and II randomized controlled trials. Arthroscopy 2022; 38: 2035–46.","DOI":"10.1016\/j.arthro.2021.11.005"},{"key":"10.3238\/arztebl.m2023.0154_ref31","doi-asserted-by":"crossref","unstructured":"Chou S-H, Shih C-L: Efficacy of different platelet-rich plasma injections in the treatment of mild-moderate knee osteoarthritis: a systematic review and meta-analysis. Int J Clin Pract 2021; 75: e14068.","DOI":"10.1111\/ijcp.14068"},{"key":"10.3238\/arztebl.m2023.0154_ref32","doi-asserted-by":"crossref","unstructured":"Sax OC, Chen Z, Mont MA, Delanois RE: The efficacy of platelet-rich plasma for the treatment of knee osteoarthritis symptoms and structural changes: a systematic review and meta-analysis. J Arthroplasty 2022; 37: 2282–90.e2.","DOI":"10.1016\/j.arth.2022.05.014"},{"key":"10.3238\/arztebl.m2023.0154_ref33","doi-asserted-by":"crossref","unstructured":"Chahla J, Cinque ME, Piuzzi NS, et al.: A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 2017; 99: 1769–79.","DOI":"10.2106\/JBJS.16.01374"},{"key":"10.3238\/arztebl.m2023.0154_ref34","doi-asserted-by":"crossref","unstructured":"Gaul F, Bugbee WD, Hoenecke HR, D‘Lima DD: A review of commercially available point-of-care devices to concentrate bone marrow for the treatment of osteoarthritis and focal cartilage lesions. Cartilage 2019; 10: 387–94.","DOI":"10.1177\/1947603518768080"},{"key":"10.3238\/arztebl.m2023.0154_ref35","doi-asserted-by":"crossref","unstructured":"Bowen JE: Technical issues in harvesting and concentrating stem cells (bone marrow and adipose). PM R 2015; 7(4 Suppl): S8–S18.","DOI":"10.1016\/j.pmrj.2015.01.025"},{"key":"10.3238\/arztebl.m2023.0154_ref36","doi-asserted-by":"crossref","unstructured":"Anz AW, Plummer HA, Cohen A, Everts PA, Andrews JR, Hackel JG: Bone marrow aspirate concentrate is equivalent to platelet-rich plasma for the treatment of knee osteoarthritis at 2 years: a prospective randomized trial. Am J Sports Med 2022; 50: 618–29.","DOI":"10.1177\/03635465211072554"},{"key":"10.3238\/arztebl.m2023.0154_ref37","doi-asserted-by":"crossref","unstructured":"Agarwal N, Mak C, Bojanic C, To K, Khan W: Meta-analysis of adipose tissue derived cell-based therapy for the treatment of knee osteoarthritis. Cells 2021; 10: 1365.","DOI":"10.3390\/cells10061365"},{"key":"10.3238\/arztebl.m2023.0154_ref38","doi-asserted-by":"crossref","unstructured":"Ding W, Xu Y-Q, Zhang Y, et al.: Efficacy and safety of intra-articular cell-based therapy for osteoarthritis: systematic review and network meta-analysis. Cartilage 2020: 1947603520942947.","DOI":"10.1177\/1947603520942947"},{"key":"10.3238\/arztebl.m2023.0154_ref39","doi-asserted-by":"crossref","unstructured":"Tan SHS, Kwan YT, Neo WJ, et al.: Intra-articular injections of mesenchymal stem cells without adjuvant therapies for knee osteoarthritis: a systematic review and meta-analysis. Am J Sports Med 2021: 363546520981704.","DOI":"10.1177\/0363546520981704"},{"key":"10.3238\/arztebl.m2023.0154_ref40","doi-asserted-by":"crossref","unstructured":"Kim SH, Djaja YP, Park YB, Park JG, Ko YB, Ha CW: Intra-articular injection of culture-expanded mesenchymal stem cells without adjuvant surgery in knee osteoarthritis: a systematic review and meta-analysis. Am J Sports Med 2019: 363546519892278.","DOI":"10.1177\/0363546519892278"},{"key":"10.3238\/arztebl.m2023.0154_ref41","doi-asserted-by":"crossref","unstructured":"Jin Z, Wang D, Zhang H, et al.: Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the global burden of disease study 2017. Ann Rheum Dis 2020; 79: 1014–22.","DOI":"10.1136\/annrheumdis-2020-217050"},{"key":"10.3238\/arztebl.m2023.0154_ref42","unstructured":"Robert Koch-Institut (RKI): 12-Monats-Pr\u00e4valenz von Arthrose in Deutschland. RKI-Bib1 2017."},{"key":"10.3238\/arztebl.m2023.0154_ref43","doi-asserted-by":"crossref","unstructured":"Allen KD, Thoma LM, Golightly YM: Epidemiology of osteoarthritis. Osteoarthritis Cartilage 2022; 30: 184–95.","DOI":"10.1016\/j.joca.2021.04.020"},{"key":"10.3238\/arztebl.m2023.0154_ref44","doi-asserted-by":"crossref","unstructured":"Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT: Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol 2019; 15: 77–90.","DOI":"10.1038\/s41584-018-0123-4"},{"key":"10.3238\/arztebl.m2023.0154_ref45","doi-asserted-by":"crossref","unstructured":"Brophy RH, Fillingham YA: AAOS Clinical Practice Guideline Summary: management of osteoarthritis of the knee (nonarthroplasty), third edition. J Am Acad Orthop Surg 2022; 30: e721–9.","DOI":"10.5435\/JAAOS-D-21-01233"},{"key":"10.3238\/arztebl.m2023.0154_ref46","doi-asserted-by":"crossref","unstructured":"Mabey T, Honsawek S: Cytokines as biochemical markers for knee osteoarthritis. World J Orthop 2015; 6: 95–105.","DOI":"10.5312\/wjo.v6.i1.95"},{"key":"10.3238\/arztebl.m2023.0154_ref47","doi-asserted-by":"crossref","unstructured":"Sanchez-Lopez E, Coras R, Torres A, Lane NE, Guma M: Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol 2022; 18: 258–75.","DOI":"10.1038\/s41584-022-00749-9"},{"key":"10.3238\/arztebl.m2023.0154_ref48","doi-asserted-by":"crossref","unstructured":"Gerwin N, Scotti C, Halleux C, et al.: Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial. Nat Med 202; 28: 2633–45.","DOI":"10.1038\/s41591-022-02059-9"},{"key":"10.3238\/arztebl.m2023.0154_ref49","doi-asserted-by":"crossref","unstructured":"Kennedy MI, Whitney K, Evans T, LaPrade RF: Platelet-rich plasma and cartilage repair. Curr Rev Musculoskelet Med 2018; 11: 573–82.","DOI":"10.1007\/s12178-018-9516-x"},{"key":"10.3238\/arztebl.m2023.0154_ref50","doi-asserted-by":"crossref","unstructured":"Pittenger MF, Mackay AM, Beck SC, et al.: Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7.","DOI":"10.1126\/science.284.5411.143"},{"key":"10.3238\/arztebl.m2023.0154_ref51","doi-asserted-by":"crossref","unstructured":"Oberbauer E, Steffenhagen C, Wurzer C, Gabriel C, Redl H, Wolbank S: Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art. Cell Regen 2015; 4: 7.","DOI":"10.1186\/s13619-015-0020-0"},{"key":"10.3238\/arztebl.m2023.0154_ref52","doi-asserted-by":"crossref","unstructured":"Ossendorff R, Walter SG, Schildberg FA, Khoury M, Salzmann GM: Controversies in regenerative medicine: should knee joint osteoarthritis be treated with mesenchymal stromal cells? Eur Cell Mater 2022; 43: 98–111.","DOI":"10.22203\/eCM.v043a09"},{"key":"10.3238\/arztebl.m2023.0154_ref53","doi-asserted-by":"crossref","unstructured":"Toyserkani NM, J\u00f8rgensen MG, Tabatabaeifar S, Jensen CH, Sheikh SP, S\u00f8rensen JA: Concise review: a safety assessment of adipose-derived cell therapy in clinical trials: a systematic review of reported adverse events. Stem Cells Transl Med 2017; 6: 1786–94.","DOI":"10.1002\/sctm.17-0031"},{"key":"10.3238\/arztebl.m2023.0154_ref54","doi-asserted-by":"crossref","unstructured":"Rackwitz L, Pullig O, N\u00f6th U: Stammzelltherapie in Deutschland. Arthroskopie 2022; 35: 359–64.","DOI":"10.1007\/s00142-022-00562-2"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T05:34:17Z","timestamp":1692855257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":54,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2023.0154","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]}}}